Editorial: The dexamethasone-suppressed corticotropin-releasing hormone test for the diagnosis of Cushing's Syndrome: What have we learned in 14 years?

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 8, 2007, Pages 2876-2878

  Nieman, Lynnette ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CORTICOTROPIN RELEASING FACTOR; CYTOCHROME P450 3A4; DEXAMETHASONE; HYDROCORTISONE; HYPERICUM PERFORATUM EXTRACT; NIFEDIPINE; PHENOBARBITAL; PHENYTOIN; RIFAMPICIN; TAMOXIFEN; TOPIRAMATE; TRANSCORTIN;

ACTH SECRETING ADENOMA; ALCOHOL CONSUMPTION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CUSHING DISEASE; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG METABOLISM; EDITORIAL; HUMAN; HYDROCORTISONE BLOOD LEVEL; LOW DRUG DOSE; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SMOKING; VALIDITY;

EID: 34547802786     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1289     Document Type: Editorial

References (15)

1. Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 269:2232-2238
2. Crapo L 1979 Cushing's syndrome: a review of diagnostic tests. Metabolism 28:955-977
3. Newell-Price J, Trainer P, Besser M, Grossman A 1998 The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 19:647-672
4. Luo G, Guenthner T, Gan LS, Humphreys WG 2004 CYP3A4 induction by xenobiotics: Biochemistry, experimental methods and impact on drug discovery and development. Curr Drug Metab 5:483-505
5. Papanicolaou DA, Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK 1998 A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 83:1163-1167
6. Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK 2007 Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102-3107
7. Liu H, Bravata DM, Cabaccan J, Raff H, Ryzen E 2005 Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol (Oxf) 63:642-649
8. Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK 1998 The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology. J Clin Endocrinol Metab 83:348-352
9. Yanovski J, Cutler Jr BG, Chrousos GB, Nieman LK, Prospective evaluation of the dexamethasone-suppressed corticotropin-releasing hormone test in the differential diagnosis of Cushing syndrome and psuedoCushing states. Program of the 77th Annual Meeting of The Endocrine Society, Washington, DC, 1995, p 99 (Abstract OR39-32)
10. Erickson D, Natt N, Nippoldt T, Young Jr WF, Carpenter PC, Petterson T, Christianson T 2007 Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism. J Clin Endocrinol Metab 92:2973-2977
11. Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, Todd JF, Meeran K 2006 Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 91:2582-2586
12. Gatta B CO, Cortet C, Martinie, Corcuff B, Roger P, Tabarin A, Reevaluation of the dex-CRH test for the differential diagnosis between Cushing's disease and pseudo-Cushing's syndrome. Program of the 88th Annual Meeting of The Endocrine Society, Boston, MA, 2006 (Abstract P2-734)
13. Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F 2007 The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Clin Endocrinol (Oxf) 66:251-257
14. Aron DC, Raff H, Findling JW 1997 Effectiveness versus efficacy: The limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 82:1780-1785
15. Cohen J, Ward G, Prins J, Jones M, Venkatesh B 2006 Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population. Intensive Care Med 32:1901-1905